Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,785 | -22,458 | -27,991 | -30,213 | -16,239 |
| Depreciation Amortization | 215 | 205 | 122 | 78 | 55 |
| Accounts payable and accrued liabilities | -1,182 | -1,918 | 2,661 | -152 | 608 |
| Other Working Capital | 460 | 2,897 | 8,767 | 3,736 | 1,477 |
| Other Operating Activity | 1,737 | 5,511 | -2,425 | 13,724 | 5,761 |
| Operating Cash Flow | $-9,556 | $-15,763 | $-18,867 | $-12,827 | $-8,338 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -74 | -250 | -249 | -95 |
| Investing Cash Flow | $N/A | $-74 | $-250 | $-249 | $-95 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | N/A | N/A | 9,459 | 11,105 |
| Common Stock Issued | 5,820 | 71 | 2 | 39,798 | 1 |
| Common Stock Repurchased | N/A | -478 | -157 | N/A | N/A |
| Financing Cash Flow | $10,820 | $-407 | $-156 | $49,257 | $11,106 |
| Exchange Rate Effect | -55 | -25 | 19 | 17 | -281 |
| Beginning Cash Position | 3,367 | 19,636 | 38,889 | 2,691 | 299 |
| End Cash Position | 4,577 | 3,367 | 19,636 | 38,889 | 2,691 |
| Net Cash Flow | $1,210 | $-16,269 | $-19,253 | $36,198 | $2,392 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,556 | -15,763 | -18,867 | -12,827 | -8,338 |
| Capital Expenditure | N/A | -74 | -250 | -249 | -95 |
| Free Cash Flow | -9,556 | -15,836 | -19,117 | -13,076 | -8,433 |